What is the appropriate evaluation for an infant with congenital diarrhea?

Evaluation of Congenital Diarrhea in Infants

For infants with suspected congenital diarrhea, first exclude common causes (infection, allergy, anatomical defects), then proceed with a systematic evaluation based on stool characteristics (watery, fatty, or bloody), followed by intestinal biopsy to assess villus-to-crypt ratio, and early genetic testing (whole exome sequencing) to identify specific monogenic disorders. 1, 2

Initial Exclusion of Common Causes

Before pursuing congenital diarrhea and enteropathies (CODEs), you must rule out:

• Infectious causes: Evaluate for bacterial pathogens (Salmonella, Shigella, Campylobacter, Yersinia, C. difficile, STEC) and viral agents, particularly in infants <3 months with fever or bloody stools 3
• Allergic causes: Cow's milk protein allergy and food protein-induced enterocolitis
• Anatomical disorders: Intestinal atresia, gastroschisis, malrotation with volvulus, necrotizing enterocolitis 4

Critical pitfall: Bloody stools in neonates often mislead clinicians toward necrotizing enterocolitis or allergic colitis, delaying CODE diagnosis 5. If diarrhea persists beyond 2 weeks despite treating these conditions, suspect CODEs.

Systematic Diagnostic Approach

Step 1: Assess Dehydration and Electrolyte Status

Evaluate immediately for dehydration, which is life-threatening in infants 3. Look specifically for:

• Hypernatremic dehydration (suggests secretory diarrhea)
• Metabolic acidosis
• Electrolyte abnormalities: Hyponatremia requiring prolonged supplementation suggests congenital sodium diarrhea; metabolic alkalosis with hypokalemia suggests congenital chloride diarrhea 2, 6

Step 2: Characterize Stool Pattern

Watery diarrhea (most common in CODEs):

• Suggests defects in electrolyte transport (congenital chloride/sodium diarrhea) or carbohydrate malabsorption (glucose-galactose malabsorption)
• Perform stool pH and reducing substances testing
• Check stool electrolytes (sodium, chloride, potassium) 2, 5

Fatty stools (steatorrhea):

• Suggests pancreatic insufficiency or bile acid malabsorption
• Measure fecal elastase 6

Bloody stools:

• Less common in CODEs but can occur with immune-mediated enteropathies
• Consider microvillus inclusion disease or congenital tufting enteropathy 2

Step 3: Perform Specific Stool Tests

• Stool reducing substances: Positive in carbohydrate malabsorption disorders 5
• Stool pH: Acidic (<5.5) suggests carbohydrate malabsorption
• Stool electrolytes: Elevated chloride (>90 mEq/L) diagnostic for congenital chloride diarrhea 2

Step 4: Trial Dietary Modifications (Diagnostic and Therapeutic)

This step provides critical diagnostic information:

• Carbohydrate-free formula (3232A): If diarrhea improves, suspect glucose-galactose malabsorption 5, 7
• Glucose challenge followed by fructose challenge: Worsening with glucose but improvement with fructose confirms glucose-galactose malabsorption 5
• Amino acid-based formula: Failure to improve rules out protein allergy 5
• Bowel rest/parenteral nutrition: Persistence despite bowel rest confirms secretory mechanism 6

Important caveat: Due to unavailability of fructose-based formulas in many settings, patients may require ketogenic formulas as a bridge until appropriate nutrition is secured 7.

Step 5: Endoscopy with Intestinal Biopsy

Perform upper endoscopy with duodenal biopsies to assess:

Normal villus-to-crypt ratio suggests:

• Defects in digestion, absorption, or transport (glucose-galactose malabsorption, congenital chloride/sodium diarrhea)
• Enteroendocrine cell defects 1

Abnormal villus-to-crypt ratio (villous atrophy) suggests:

• Microvillus inclusion disease
• Congenital tufting enteropathy
• Immune-mediated enteropathies 1, 2

Request electron microscopy when available, as it can identify characteristic features of microvillus inclusion disease (microvillus inclusions) and congenital tufting enteropathy (focal epithelial tufts) 2.

Step 6: Genetic Testing (Early Implementation)

Initiate whole exome sequencing or targeted gene panel early in the evaluation process, not as a last resort 1, 2. This approach reduces time to definitive diagnosis and prevents prolonged diagnostic odysseys.

Key genes to evaluate based on presentation:

• SLC5A1: Glucose-galactose malabsorption 5, 7
• SLC26A3: Congenital chloride diarrhea
• SPINT2: Congenital sodium diarrhea
• MYO5B, STX3: Microvillus inclusion disease
• EPCAM: Congenital tufting enteropathy
• AGR2: Recently identified cause with multisystem involvement 6

Genetic testing is particularly important with consanguineous parents, as autosomal recessive inheritance is common in CODEs 6, 7.

Management Priorities During Evaluation

While pursuing diagnosis:

• Aggressive fluid and electrolyte replacement: Specific supplementation based on deficits (sodium for congenital sodium diarrhea, fructose for glucose-galactose malabsorption) 2, 6
• Parenteral nutrition: Often required but monitor for complications (fungemia, cholestasis) 7
• Monitor for nephrocalcinosis: Can develop with chronic dehydration and electrolyte imbalances 7
• Growth monitoring: Failure to thrive is universal and requires aggressive nutritional support 2

Long-term Considerations

Some CODEs (microvillus inclusion disease, severe congenital tufting enteropathy) may ultimately require intestinal transplantation if parenteral nutrition fails or complications develop 2. Others (glucose-galactose malabsorption, congenital chloride diarrhea) can be managed with dietary modifications and have better long-term outcomes 5, 7.

The prognosis varies dramatically by specific diagnosis, making early genetic confirmation essential for prognostication and family counseling 2, 4.